Patents by Inventor Lucas J. Thompson

Lucas J. Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158837
    Abstract: Provided herein are methods of identifying genomic region(s) predictive of an outcome of treatment with a cell therapy and/or of a phenotype of function of the cells. In some embodiments, the methods include epigenetic and/or epigenomic analyses of the cells in connection with methods for preparing engineered cells for cell therapy and/or predicting response to a cell therapy, e.g., engineered cells for cell therapy. In some embodiments, the methods include steps to assess, characterize and analyze changes or modifications in an epigenetic property of gene region or regions, such as chromatin accessibility, nucleosome occupancy, histone modification, spatial chromosomal conformation, transcription factor occupancy and/or DNA methylation. In some embodiments, the epigenetic and/or epigenomic analysis includes determining the epigenetic properties of a cell, e.g., an engineered cell for cell therapy.
    Type: Application
    Filed: October 17, 2023
    Publication date: May 16, 2024
    Applicant: Juno Therapeutics, Inc.
    Inventors: Mark L. BONYHADI, David G. KUGLER, Timothy G. JOHNSTONE, Ronald James HAUSE, Jr., Lucas J. THOMPSON, Ryan P. LARSON
  • Publication number: 20240118258
    Abstract: An apparatus includes a first member having a housing that encloses a power source and a controller, a second member coupled to the first member that is seeded with a target product, and a sensing module coupled to the first member to allow power from the power source to be transmitted to the sensing module and sensor data from the sensing module to be transmitted to the controller. The sensing module including a sensor oriented toward at least a portion of the second member. The sensor configured to obtain sensor data associated with at least one characteristic of the target product.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 11, 2024
    Applicant: Running Tide Technologies, Inc.
    Inventors: Luca MASTRANGELO, William JOHNSON, Josh HILL, Timothy J. DYSON, Jacob F. HAGLER, Charles B.W. HALVORSON, Philipp Max WERMINGHAUSEN, Andrew Clyde THOMPSON
  • Patent number: 11821027
    Abstract: Provided herein are methods of identifying genomic region(s) predictive of an outcome of treatment with a cell therapy and/or of a phenotype of function of the cells. In some embodiments, the methods include epigenetic and/or epigenomic analyses of the cells in connection with methods for preparing engineered cells for cell therapy and/or predicting response to a cell therapy, e.g., engineered cells for cell therapy. In some embodiments, the methods include steps to assess, characterize and analyze changes or modifications in an epigenetic property of gene region or regions, such as chromatin accessibility, nucleosome occupancy, histone modification, spatial chromosomal conformation, transcription factor occupancy and/or DNA methylation. In some embodiments, the epigenetic and/or epigenomic analysis includes determining the epigenetic properties of a cell, e.g., an engineered cell for cell therapy.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: November 21, 2023
    Assignee: Juno Therapeutics, Inc.
    Inventors: Mark L. Bonyhadi, David G. Kugler, Timothy G. Johnstone, Ronald James Hause, Jr., Lucas J. Thompson, Ryan P. Larson